Drug Profile
Leptospirosis vaccine
Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Leptospirosis
Most Recent Events
- 22 Feb 1995 Preclinical development for Leptospirosis in USA (Unknown route)